Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
TRIUMPH-4 (retatrutide, 68 weeks): Discontinuation due to AEs: 12.2% (9 mg), 18.2% (12 mg) vs 4.0% placebo Key characteristics: Highest GI adverse event rates among the drugs compared here Dysesthesia is a novel safety signal -- abnormal touch sensations affecting up to 21% at the 12 mg dose, not seen in Phase 2
More from PlexusDx: GLP 1 What Is, GLP 1 Receptor Agonist, GLP 1 Drugs, GLP 1 Hormone
Elimination Diet This plan is suited to help uncover possible food sensitivities
As a member, you'll gain access to a dedicated care team, tailored treatment plans, and ongoing monitoring to optimize your health outcomes
Exposure to sunlight can help psoriasis symptoms
US$ 25.56
US$ 27.21
US$ 26.50
US$ 20.20
US$ 25.74
